This announcement is a separate document:
開拓藥業-B：(1) 截至2022年12月31日止年度之 年度業績公告； (2) 建議修訂組織章程大綱及細則； 及 (3) 建議增加法定股本
KINTOR PHARMA-B: (1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022; (2) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (3) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.